Found: 5
Select item for more details and to access through your institution.
The 17‐gene stemness score associates with relapse risk and long‐term outcomes following allogeneic haematopoietic cell transplantation in acute myeloid leukaemia.
- Published in:
- EJHaem, 2022, v. 3, n. 3, p. 873, doi. 10.1002/jha2.466
- By:
- Publication type:
- Article
Optimal duration of imatinib treatment/deep molecular response for treatment‐free remission after imatinib discontinuation from a Canadian tyrosine kinase inhibitor discontinuation trial.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 4, p. 779, doi. 10.1111/bjh.17447
- By:
- Publication type:
- Article
Genome-wide genotype-based risk model for survival in acute myeloid leukaemia patients with normal karyotype.
- Published in:
- British Journal of Haematology, 2013, v. 163, n. 1, p. 62, doi. 10.1111/bjh.12492
- By:
- Publication type:
- Article
ABCB1 polymorphisms predict imatinib response in chronic myeloid leukemia patients: a systematic review and meta-analysis.
- Published in:
- Pharmacogenomics Journal, 2015, v. 15, n. 2, p. 127, doi. 10.1038/tpj.2014.54
- By:
- Publication type:
- Article
Flow cytometry-based measurable residual disease (MRD) analysis identifies AML patients who may benefit from allogeneic hematopoietic stem cell transplantation.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 4, p. 1187, doi. 10.1007/s00277-024-05639-6
- By:
- Publication type:
- Article